Latest Cash Flow News

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.

Corporate Travel Management revises down its FY25 revenue outlook by 4%, citing tariff and economic uncertainties in North America and Asia, while strong client wins bolster confidence for FY26.

Vmoto Limited reported a 16% decline in total unit sales for 1Q25, offset by a strong cash position and strategic investments in e-mobility solutions and production capacity.

Capstone Copper delivered a standout first quarter in 2025 with record sulphide copper output and adjusted EBITDA more than doubling year-over-year, underpinning its confidence in meeting full-year guidance and advancing key growth projects.

Redivium Limited has launched its Trading Division and secured key agreements as it pushes forward with European battery recycling projects, though funding challenges remain.

VDM Group Limited faces suspension on the ASX due to a joint venture dispute in Angola, halting exploration activities. The company is pivoting towards new critical minerals projects in Australia to restore trading and investor confidence.

MCS Services Limited reported a solid cash position of $1.23 million at quarter-end and is actively exploring the sale of its Traffic Business subsidiary while awaiting key tender results.

Stanmore Resources has released an updated maiden Reserves Statement for its Isaac Downs Extension metallurgical coal project, confirming 52 million tonnes of Run of Mine coal reserves and a robust +20-year mine life supported by existing infrastructure.

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.